Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Juan Esteban Gómez‐Mesa"'
Autor:
Juan Esteban Gómez‐Mesa, Juliana María Gutiérrez‐Posso, Manuela Escalante‐Forero, David Esteban Eraso‐Bolaños, Mark H. Drazner, Daniel Quesada‐Chaves, Alexander Romero‐Guerra, Eduardo R. Perna, Amada Álvarez‐Sangabriel, Víctor Rossel, Walter Alarco, Mario Speranza
Publikováno v:
ESC Heart Failure, Vol 11, Iss 6, Pp 3805-3813 (2024)
Abstract Aims Heart failure (HF) is a highly prevalent and progressive condition associated with significant morbidity and mortality rates. Acute decompensated HF precipitates millions of hospitalizations each year. Despite therapeutic advances, the
Externí odkaz:
https://doaj.org/article/f5f92b72363d49e4a4ad217c3ce0884e
Autor:
Fernán Mendoza-Beltrán, Luis Eduardo Echeverría, Alex Rivera-Toquica, Hugo Ernesto Osorio-Carmona, Alejandro Posada-Bastidas, Juan Camilo García, Alejandro David Ochoa-Morón, Balkis Rolong, Fernando Manzur-Jatin, José Ignacio Mosquera-Jiménez, Oscar Alfredo Pacheco-Jiménez, Álvaro Hernán Rodríguez-Cerón, Patricia Rodríguez-Gómez, Clara Saldarriaga, Juan Esteban Gómez-Mesa
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Anemia represents a commonly reported comorbidity in patients diagnosed with heart failure (HF), related with a higher risk of unfavorable outcomes such as recurrent hospitalizations and mortality. There is a lack of evidence in L
Externí odkaz:
https://doaj.org/article/03b7759c43a04c9e821e632ec56b5713
Autor:
Luis Eduardo Echeverría, Clara Saldarriaga, Sebastián Campbell-Quintero, Lisbeth Natalia Morales-Rodríguez, Juan David López-Ponce de León, Andrés Felipe Buitrago, Erika Martínez-Carreño, Jorge Alberto Sandoval-Luna, Alexis Llamas, Gustavo Adolfo Moreno-Silgado, Julián Vanegas-Eljach, Nelson Eduardo Murillo-Benítez, Ricardo Gómez-Paláu, Alex Arnulfo Rivera-Toquica, Juan Esteban Gómez-Mesa, RECOLFACA research group
Publikováno v:
Biomédica: revista del Instituto Nacional de Salud, Vol 44, Iss Sp. 1, Pp 182-197 (2024)
Introduction. Heart failure and type 2 diabetes mellitus are critical public health issues. Objective. To characterize the risk factors for mortality in patients with heart failure and type 2 diabetes mellitus from a large registry in Colombia and to
Externí odkaz:
https://doaj.org/article/95cbe305709245f39003f32dc7b86344
Autor:
Juan Esteban Gómez-Mesa, Clara Saldarriaga, Alex Arnulfo Rivera-Toquica, Silfredo Arrieta-González, Alfonso Muñoz-Velásquez, Eduardo José Echeverry-Navarrete, Julián Rodrigo Lugo-Peña, Juan Alberto Cerón, Oscar Sveins Rincón-Peña, Luis Eduardo Silva-Diazgranados, Hugo Ernesto Osorio-Carmona, Alejandro Posada-Bastidas, Juan Camilo García, Alejandro David Ochoa-Morón, Luis Eduardo Echeverría
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 53, Iss , Pp 101448- (2024)
Background: The value of Sodium-glucose cotransporter-2 inhibitors (SGLT-2 inhibitor) therapy in individuals with heart failure with preserved EF (HFpEF) was unknown until the EMPEROR-Preserved trial. We aimed to assess the proportion of patients wit
Externí odkaz:
https://doaj.org/article/ab6e7264f06a4dbcbd92f67ee0640f68
Autor:
Erika Martínez-Carreño, Luis Eduardo Echeverría, Alex Rivera-Toquica, Mario Hernán Zarama-Márquez, Elkin Giovanni Ramírez-Puentes, Rafael Ignacio Bustamante, Rolando Palacio, Luis Manuel Ávila-Barros, Sebastián Campbell-Quintero, Lisbeth Natalia Morales-Rodríguez, Juan David López-Ponce de León, Andrés Felipe Buitrago, Jorge Alberto Sandoval-Luna, Clara Saldarriaga, Juan Esteban Gómez-Mesa
Publikováno v:
Kidney & Blood Pressure Research, Vol 49, Iss 1, Pp 165-172 (2024)
Introduction: Arterial hypertension represents one of the main comorbidities observed in patients with heart failure (HF) and one of the main risk factors for its development. Despite this, studies assessing this hypertensive etiology are scarce in L
Externí odkaz:
https://doaj.org/article/cd3ffc818a1b4aa3a0e0f1a07bbdc5a6
Autor:
Jorge Alberto Sandoval-Luna, Alex Rivera-Toquica, Clara Saldarriaga, Erika Martínez-Carreño, Alexis Llamas, Gustavo Adolfo Moreno-Silgado, Julián Vanegas-Eljach, Nelson Eduardo Murillo-Benítez, Ricardo Gómez-Palau, Carlos Andrés Arias-Barrera, Fernán Mendoza-Beltrán, Diego Hernán Hoyos-Ballesteros, Carlos Andrés Plata-Mosquera, Luis Eduardo Echeverría, Juan Esteban Gómez-Mesa
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 9, p 265 (2024)
The impact of chronic obstructive pulmonary disease (COPD) on heart failure (HF) has yet to be well assessed in the Latin American population. This study aimed to analyze the impact of COPD on HF patients from the Colombian Heart Failure Registry (RE
Externí odkaz:
https://doaj.org/article/3c8bd62dee4c476eb1b4736030de6db7
Autor:
Wikler Bernal Torres, Juan Pablo Arango-Ibanez, Juan Manuel Montero Echeverri, Santiago Posso Marín, Armando Alvarado, Andrés Ulate, Paola Oliver, Ivan Criollo, Wilbert German Yabar Galindo, Sylvia Sandoval, William Millán Orozco, Fernando Verdugo Thomas, Franco Appiani Florit, Andrés Buitrago, Alejandra Ines Christen, Igor Morr, Luiz Carlos Santana Passos, Marlon Aguirre, Roger Martín Correa, Hoover O. León-Giraldo, Andrea Alejandra Arteaga-Tobar, Juan Esteban Gómez-Mesa
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 7, p 210 (2024)
Pre-existing (chronic) atrial fibrillation (AF) has been identified as a risk factor for cardiovascular complications and mortality in patients with COVID-19; however, evidence in Latin America (LATAM) is scarce. This prospective and multicenter stud
Externí odkaz:
https://doaj.org/article/4eea34de08614bee8fde41beeb8b988b
Autor:
Juan Pablo Arango-Ibanez, Brayan Daniel Córdoba-Melo, Juliana María Gutiérrez Posso, Mario Miguel Barbosa-Rengifo, Cesar J. Herrera, Miguel Angel Quintana Da Silva, Andrés Felipe Buitrago, María Lorena Coronel Gilio, Freddy Pow-Chong-Long, Juan Esteban Gómez-Mesa
Publikováno v:
Viruses, Vol 16, Iss 7, p 1028 (2024)
Long COVID presents with diverse symptoms after COVID-19. Different clusters of symptoms have been reported; however, their persistence beyond 2 years after COVID-19 remains unclear. In this cohort study, we prospectively evaluated individuals with p
Externí odkaz:
https://doaj.org/article/141830936d6b4b20b960b301a2289508
Autor:
Juan Esteban Gómez-Mesa, Manuela Escalante, Juan Andrés Muñoz-Ordoñez, Valeria Azcárate-Rodriguez, Juan David Peláez-Martínez, Andrea Alejandra Arteaga-Tobar, Hoover León-Giraldo, Andrea Valencia-Orozco, Eduardo Roque Perna, Alexander Romero, Iván Mendoza, Fernando Wyss, José Luis Barisani, Mario Speranza, Walter Alarco, Cesar Herrera, Julián Lugo-Peña, Liliana Patricia Cárdenas-Aldaz, Victor Rossel, Daniel Sierra
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 7, p 205 (2024)
Background: The COVID-19 pandemic has highlighted a correlation between cardiac complications and elevated cardiac biomarkers, which are linked to poorer clinical outcomes. Objective: This study aims to determine the clinical impact of cardiac biomar
Externí odkaz:
https://doaj.org/article/ff96c19debba497eac0af4f620587cee
Autor:
Mario Speranza, Juan D. López-López, Pedro Schwartzmann, Igor Morr, María Juliana Rodríguez-González, Andrés Buitrago, Freddy Pow-Chon-Long, Luiz Carlos Passos, Víctor Rossel, Eduardo Roque Perna, Manuela Escalante, Alexander Romero, Andrea Alejandra Arteaga-Tobar, Daniel Quesada, Walter Alarco, Juan Esteban Gómez-Mesa
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 2, p 34 (2024)
Since early 2020, different studies have shown an increased prevalence of COVID-19 and poorer prognosis in older adults with cardiovascular comorbidities. This study aimed to assess the impact of heart failure (HF) on cardiovascular complications, in
Externí odkaz:
https://doaj.org/article/0e00090aa90343cba0efa212c9765556